Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sean Carrick currently holds 22,934,007 shares of Nascent Biotech Inc. (NBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean Carrick has been a net buyer of NBIO stock. They have purchased $1.5M and sold $0 worth of shares.
Sean Carrick's most recent insider trade was on Mar 31, 2024, when they sold 225,000 shares at $0.18 per share.
Sean Carrick serves as Executive at Nascent Biotech Inc. (NBIO). They have executed 39 insider transactions totaling $1.5M over their tenure at the company.
Sean Carrick holds the position of Executive at Nascent Biotech Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Sean Carrick has shown a buying trading pattern, with $1.5M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Sean Carrick was on Sep 4, 2015, when they sold $1.5M worth of NBIO shares. This transaction involved 1,028,901 shares at $1.45 per share.
Sean Carrick currently owns 22,934,007 shares of Nascent Biotech Inc. (NBIO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sean Carrick's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sean Carrick has 39 Form 4 filings on record as an insider at Nascent Biotech Inc..
Set alerts for Sean Carrick and 40,000+ other insiders.